| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |